PROMISE study launches to investigate genetic factors influencing prostate cancer outcomes

SCCA’s Heather Cheng, MD, Ph.D., discussed the rollout of the PROMISE registry for prostate cancer with Urology Times.

Read the article

Related Stories
Understanding the genetic link to prostate cancer helps James DeLong finetune treatment and protect his family
Understanding the genetic link to prostate cancer helps James DeLong finetune treatment and protect his family

As a lifelong educator, James DeLong believes in the power of research. So when he turned 50, he decided to sign up for a prostate cancer research study enrolling healthy men. The study involved an initial rectal exam plus an annual blood draw and questionnaire.